Clinical Trial Update: Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ThermoDox in combination with standardized radiofrequency ablation for hepatocellular carcinoma has completed and results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: Imunon | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2024-08-20